SETDB1 and hepatocellular carcinoma: It was found that miR-621 could inhibit the expression of SETDB1 by targeting its 3' UTR, and the miR-621/SETDB1 signalling axis further activated the p53 signaling pathway to enhance the radiosensitivity of HCC [70].